CN101528124A - 用于淋巴系统成像的方法 - Google Patents

用于淋巴系统成像的方法 Download PDF

Info

Publication number
CN101528124A
CN101528124A CNA200780038841XA CN200780038841A CN101528124A CN 101528124 A CN101528124 A CN 101528124A CN A200780038841X A CNA200780038841X A CN A200780038841XA CN 200780038841 A CN200780038841 A CN 200780038841A CN 101528124 A CN101528124 A CN 101528124A
Authority
CN
China
Prior art keywords
lymph
contrast agent
image
mammal
lymphatic system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200780038841XA
Other languages
English (en)
Chinese (zh)
Inventor
V·雅克
P·D.·卡拉万
B·米赛尔维茨
H-J·魏因曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epix Pharmaceuticals Inc
Original Assignee
Bayer Schering Pharma AG
Epix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma AG, Epix Pharmaceuticals Inc filed Critical Bayer Schering Pharma AG
Publication of CN101528124A publication Critical patent/CN101528124A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/418—Evaluating particular organs or parts of the immune or lymphatic systems lymph vessels, ducts or nodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Signal Processing (AREA)
  • Endocrinology (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
CNA200780038841XA 2006-08-17 2007-08-16 用于淋巴系统成像的方法 Pending CN101528124A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83848806P 2006-08-17 2006-08-17
US60/838,488 2006-08-17

Publications (1)

Publication Number Publication Date
CN101528124A true CN101528124A (zh) 2009-09-09

Family

ID=39083140

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200780038841XA Pending CN101528124A (zh) 2006-08-17 2007-08-16 用于淋巴系统成像的方法

Country Status (7)

Country Link
US (1) US20080044358A1 (https=)
EP (1) EP2053968A4 (https=)
JP (1) JP5563299B2 (https=)
KR (1) KR101336505B1 (https=)
CN (1) CN101528124A (https=)
CA (1) CA2660717A1 (https=)
WO (1) WO2008022263A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113905659A (zh) * 2019-02-04 2022-01-07 麻省理工学院 用于淋巴结和血管成像的系统和方法

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090024022A1 (en) * 2006-10-25 2009-01-22 Siemens Corporate Research, Inc. System and method for lymph node imaging using co-registration of ct and mr imagery
US9747789B2 (en) 2013-03-31 2017-08-29 Case Western Reserve University Magnetic resonance imaging with switched-mode current-source amplifier having gallium nitride field effect transistors for parallel transmission in MRI
US10076264B2 (en) 2013-03-31 2018-09-18 Case Western Reserve University System and method for quantitative magnetic resonance (MR) analysis using T1 mapping
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
RU2755181C2 (ru) 2016-11-28 2021-09-14 Байер Фарма Акциенгезельшафт Новые хелатные соединения гадолиния с высокой релаксивностью для применения в магнитно-резонансной визуализации
CN113164628A (zh) 2018-11-23 2021-07-23 拜耳股份有限公司 造影介质制剂及其制备方法
WO2023177683A1 (en) * 2022-03-14 2023-09-21 The Board Of Trustees Of The Leland Stanford Junior University Devices, systems, and methods for treating volume overload

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0289304A (ja) * 1988-09-27 1990-03-29 Kitamura Kiden Kk 巻鉄心用帯材の切抜方法
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
US5843399A (en) * 1990-04-06 1998-12-01 Schering Aktiengesellschaft DTPA monoamides for MRI
DE4011684A1 (de) * 1990-04-06 1991-10-10 Schering Ag Dtpa-monoamide, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
AU4778893A (en) * 1992-07-21 1994-02-14 General Hospital Corporation, The System of drug delivery to the lymphatic tissues
GB9216082D0 (en) * 1992-07-28 1992-09-09 Univ Nottingham Lymphatic delivery composition
TW319763B (https=) * 1995-02-01 1997-11-11 Epix Medical Inc
DE19525924A1 (de) * 1995-07-04 1997-01-09 Schering Ag Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
JPH10120597A (ja) * 1996-10-22 1998-05-12 Eiken Chem Co Ltd リンパ節高集積性コロイド粒子
KR20010030854A (ko) * 1997-10-02 2001-04-16 로퍼, 랜달 비. 인터벤셔날 요법을 모니터하기 위한 콘트라스트 강화된진단 영상화 방법
US6444192B1 (en) * 1999-02-05 2002-09-03 The Regents Of The University Of California Diagnostic imaging of lymph structures
ES2228536T3 (es) * 1999-05-14 2005-04-16 The Regents Of The University Of California Soporte macromolecular a base de dextrano para un farmaco y suministro de un agente de diagnosotico.
BR0013171A (pt) * 1999-07-29 2002-05-28 Epix Medical Inc Agentes multimericos para formação de imagem de objetivação através de ligação multi-local
DE19948651B4 (de) 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung
US6818203B2 (en) * 2000-08-11 2004-11-16 Schering Aktiengesellschaft Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses
US7160535B2 (en) * 2001-10-31 2007-01-09 Bracco International Bv Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications
US6549798B2 (en) * 2001-02-07 2003-04-15 Epix Medical, Inc. Magnetic resonance angiography data
US6705476B2 (en) * 2001-08-22 2004-03-16 Central Metal Products, Inc. Shipping rack with torsionally loaded shelf
US20050171424A1 (en) * 2004-01-13 2005-08-04 The Gov. Of The Usa As Rep. By The Secretary Of The Dept. Of Health And Human Services Methods for imaging the lymphatic system using dendrimer-based contrast agents
US8097283B2 (en) * 2004-01-15 2012-01-17 Mount Sinai School Of Medicine Methods and compositions for imaging

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113905659A (zh) * 2019-02-04 2022-01-07 麻省理工学院 用于淋巴结和血管成像的系统和方法

Also Published As

Publication number Publication date
EP2053968A2 (en) 2009-05-06
EP2053968A4 (en) 2015-10-21
WO2008022263A2 (en) 2008-02-21
KR20090045343A (ko) 2009-05-07
WO2008022263A3 (en) 2008-12-11
JP2010501009A (ja) 2010-01-14
US20080044358A1 (en) 2008-02-21
JP5563299B2 (ja) 2014-07-30
KR101336505B1 (ko) 2013-12-05
CA2660717A1 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
CA2303426C (en) Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
Kiessling et al. Contrast agents and applications to assess tumor angiogenesis in vivo by magnetic resonance imaging
JP5563299B2 (ja) リンパ系撮像方法
Tan et al. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model
Wu et al. Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer
US9952300B2 (en) Dynamic contrast enhanced MRI method and agents for the assessment of the macromolecular transport within pathologic tissues
Su et al. Multimodality imaging of angiogenesis in a rabbit atherosclerotic model by GEBP11 peptide targeted nanoparticles
Barentsz et al. Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients
Lee et al. Hepatocellular nodules in liver cirrhosis: MR evaluation
JP2003505519A5 (https=)
Wu et al. Peptide targeted high-resolution molecular imaging of prostate cancer with MRI
US20060204443A1 (en) Methods for tumor treatment using dendrimer conjugates
JP6145612B2 (ja) 高分子ナノ粒子複合体、及びそれを含むｍｒｉ造影用組成物
US20180185520A1 (en) Collagen imaging compostions
Adzamli et al. Albumin‐binding MR blood pool agents as MRI contrast agents in an intracranial mouse glioma model
US20050171424A1 (en) Methods for imaging the lymphatic system using dendrimer-based contrast agents
Boschi et al. Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-Albumin and B-22956/1 in an experimental model of mammary carcinoma
JP4786112B2 (ja) 金属イオンキレート化錯体と共役させた胆汁酸誘導体の微小血管の診断評価のための使用
Zhou et al. Comparison of Gd [DTPA‐bis (2‐aminoethoxy) ethane] polymeric contrast agent with gadodiamide injection for interstitial MR lymphography: Experimental study with rabbits
CA2271735C (en) Magnetic resonance blood pool agents
HK1131533A (en) Methods for lymph system imaging
Wu et al. MR molecular imaging of prostate cancer with a small molecular CLT1 peptide targeted contrast agent
KR20250158760A (ko) 콜라겐 및 피브린 영상화를 위한 조영제
US10301358B2 (en) Collagen imaging compositions
Harvey Paramagnetic Probes for Magnetic Resonance

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1131533

Country of ref document: HK

ASS Succession or assignment of patent right

Free format text: FORMER OWNER: SCHERING AG

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20100902

Address after: Massachusetts USA

Applicant after: Epix Pharm Inc. (DE)

Address before: Massachusetts USA

Applicant before: Epix Pharm Inc. (DE)

Co-applicant before: Schering AG

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090909

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1131533

Country of ref document: HK